Gennova Biopharma's COVID-19 Vaccine Found To Be Safe In Early Trials
[email protected]13 Sep, 2021News
Gennova Biopharmaceuticals' COVID-19 vaccine has been found to be safe and effective in an early-stage study, according to India's drug regulator. The company has been allowed to conduct further studies to test efficacy and other parameters. The Maharashtra-based pharmaceutical company plans to conduct a late stage trial at close to 25 sites in the country. Gennova's vaccine production is partially funded by the Centre, which gives it access to the Ministry of Science and Tec
Related Bookmarks
- Vidhan Kesari newspaper read Online
- Gennova Gets DCGI Nod To Conduct Phase 2,3 Trials Of Its MRNA COVID-19 Vaccine
- P2F Market is Booming and How
- Adrien Thominet is the new Executive Chairman of ECS Group
- Home Movers Buffalo NY
- Painting Services Abu Dhabi
- Consultant For Starting A New Business |rocket30.com
- 2 more Victims of September 11, 2001 Terrorist Attacks identified
- Wholesale DID
- US is working with New Taliban Government to Evacuate 100 Americans
Recent Profiles
Fayetteville Plumbing Services
Franklin Dental & Braces
68vip
Flowers South Croydon
Tonywaltonuk
Clearview Acuherb Clinic
Lvftpersonaltraining
23win
Az888
Trash Panda Dumpster Rental Salt Lake City